Skip to main content

Acute Lymphoblastic Leukaemia: Achievements and Prospects

  • Chapter
Paediatric Oncology

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 88))

Abstract

The last major improvement in the outlook for children with acute lymphoblastic leukaemia (ALL) took place around the late 1960s and early 1970s, with the more or less simultaneous introduction of early prophylactic treatment of the central nervous system (CNS) and continuing combination chemotherapy. Since that time, although detailed examination of all aspects of treatment has led to minor advances, there has been no further great stride forward, and treatment remains eventually unsuccessful in about half of all such patients. Meanwhile, however, real advances have been made in the classification of the acute leukaemias, and the prognostic significance of various presenting features has been more closely defined. This new knowledge has influenced the design of therapeutic trials, but it remains to be seen whether prognostic differences can be overcome by the use of more aggressive approaches to the less favourable groups.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukaemias. Br J Haematol 33: 451–458

    Article  PubMed  CAS  Google Scholar 

  2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C, The French-American-British (FAB) Cooperative Group (1981) The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol 47: 553–561

    Article  PubMed  CAS  Google Scholar 

  3. Bloomfield CD, Peterson LC, Yunis JJ, Brunning RD (1977) The Philadelphia chromosome (Ph’) in adults presenting with acute leukaemia: a comparison of Ph’ + and Ph’ — patients. Br J Haematol 36: 347–358

    Article  PubMed  CAS  Google Scholar 

  4. Chessells JM (1982) Some aspects of treatment of childhood leukaemia. In: Valman HB (ed) Topics in paediatrics 3. Recent advances in paediatric therapeutics. Pitman, London, pp 129–138

    Google Scholar 

  5. Chessells JM, Breatnach F (1981) Late marrow relapses in childhood acute lymphoblastic leukaemia. Br Med J 283: 649–751

    Article  Google Scholar 

  6. Chessells JM, Hardisty RM, Rapson NT, Greaves MF (1977) Acute lymphoblastic leukaemia in children: classification and prognosis. Lancet 2: 1307–1309

    Article  PubMed  CAS  Google Scholar 

  7. Chessells JM, Janossy G, Lawler SD, Secker-Walker LM (1979) The Ph’ chromosome in childhood leukaemia. Br J Haematol 41: 25–41

    Article  PubMed  CAS  Google Scholar 

  8. Cornbleet MA, Chessells JM (1978) Bone-marrow relapse in acute lymphoblastic leukaemia in childhood. Br Med J 2: 104–106

    Article  PubMed  CAS  Google Scholar 

  9. Eiser C (1978) Intellectual abilities among survivors of childhood leukaemia as a function of CNS irradiation. Arch Dis Child 53: 391–395

    Article  PubMed  CAS  Google Scholar 

  10. Eiser C (1980) Effects of chronic illness on intellectual development. A comparison of normal children with those treated for childhood leukaemia and solid tumours. Arch Dis Child 55: 766–770

    Article  PubMed  CAS  Google Scholar 

  11. Ekert H, Ellis WM, Waters KD, Matthews RM (1979) Poor outlook for childhood acute lymphoblastic leukaemia with relapse. Med J Aust 2: 224–226

    PubMed  CAS  Google Scholar 

  12. Freeman AI, Wang JJ, Sinks LF (1977) High dose methotrexate in acute lymphocytic leukemia. Cancer Treat Rep 61: 727–731

    PubMed  CAS  Google Scholar 

  13. George SL, Aur RJA, Mauer AM, Simone JV (1979) A reappraisal of the results of stopping therapy in childhood leukemia. New Engl J Med 300: 269–273

    Article  PubMed  CAS  Google Scholar 

  14. Greaves MF (1981) Biology of acute lymphoblastic leukaemia. Leukaemia Research Fund. 16th Annual Guest Lecture

    Google Scholar 

  15. Greaves MF, Brown G, Rapson NT, Lister TA (1975) Antisera to acute lymphoblastic leukaemia cells. Clin Immunol Immunopathol 4: 67–84

    Article  PubMed  CAS  Google Scholar 

  16. Greaves MF, Verbi W, Vogler L, Cooper M, Ellis R, Ganeshaguru K, Hoffbrand V, Janossy G, Bollum FJ (1979) Antigenic and enzymatic phenotypes of the pre-B subclass of acute lymphoblastic leukaemia. Leukaemia Res 3: 353–362

    Article  CAS  Google Scholar 

  17. Greaves MF, Delia D, Janossy G, Rapson N, Chessells J, Woods M, Prentice G (1980) Acute lymphoblastic leukaemia associated antigen. IV. Expression on non-leukaemic `lymphoid’ cells. Leuk Res 4: 15–32

    Article  PubMed  CAS  Google Scholar 

  18. Greaves MF, Janossy G, Peto J, Kay HEM (1981) Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis. Br J Haematol 48: 179–197

    PubMed  CAS  Google Scholar 

  19. Gribbin MA, Hardisty RM, Chessells JM (1977) Long-term control of central nervous system leukaemia. Arch Dis Child 52: 673–678

    Article  PubMed  CAS  Google Scholar 

  20. Ha K, Baba K, Ikeda T, Nishida M, Yabuuchi H, Takahashi M (1980) Application of live varicella vaccine to children with acute leukemia or other malignancies without suspension of anticancer therapy. Pediatrics 65: 346–350

    PubMed  CAS  Google Scholar 

  21. Haghbin M (1976) Chemotherapy of acute lymphoblastic leukemia in children. Am J Hematol 1: 201–209

    Article  PubMed  CAS  Google Scholar 

  22. Hardisty RM (1982) Prophylaxis of central-nervous-system leukaemia: British experience, 1970–80. Proceedings of the International Pediatric Oncology Conference, Rome, October 1981, pp 140–143

    Google Scholar 

  23. Hardisty RM, Till MM (1968) Acute leukaemia 1959–1964: factors affecting prognosis. Arch Dis Child 43: 107–115

    Article  PubMed  CAS  Google Scholar 

  24. Hardisty RM, McElwain TJ, Darby CW (1969) Vincristine and prednisolone for the induction of remission in acute childhood leukaemia. Br Med J 2: 662–665

    Article  PubMed  CAS  Google Scholar 

  25. Hardisty RM, Till MM, Peto J (1981) Acute lymphoblastic leukaemia: four-year survivals old and new. J Clin Pathol 34: 249–253

    Article  PubMed  CAS  Google Scholar 

  26. Henze G, Langermann H-J, Ritter J, Schellong G, Riehm H-J (1981) Treatment strategy for different risk groups in childhood acute lymphoblastic leukaemia. A report from the BFM Study Group. In: Neth R, Gollo RC, Hofschneider PH, Monnweiler K (eds) Modern trends in human leukaemia IV. Springer-Verlag, Heidelberg, pp 87–93

    Google Scholar 

  27. Hughes WT, Feldman S, Aur RJA, Verzosa MS, Hustu HO, Simone JV (1975) Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis. Cancer 36: 2004–2009

    Article  PubMed  CAS  Google Scholar 

  28. Hughes WT, Kuhn S, Chaudhary S, Feldman S, Verzosa M, Aur RJA, Pratt C, George SL (1977) Successful chemo-prophylaxis for Pneumocystis carinii pneumonitis. New Engl J Med 297: 1419–1426

    Article  PubMed  CAS  Google Scholar 

  29. Hustu HO, Aur RJA (1978) Extramedullary leukaemia. Clin Haematol 7: 313–337

    PubMed  CAS  Google Scholar 

  30. Johnson FL, Thomas ED, Clark BS, Chard RL, Hartmann JR, Storb R (1981) A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukaemia in second or subsequent remission. N Engl J Med 305: 846–851

    Article  PubMed  CAS  Google Scholar 

  31. Kay HEM, Knapton PJ, O’Sullivan JP, Wells DG, Harris DG, Harris RF, Innes EM, Stuart J, Schwartz FCM, Thompson EN (1972) Encephalopathy in acute leukaemia associated with methotrexate therapy. Arch Dis Child 47: 344–354

    Article  PubMed  CAS  Google Scholar 

  32. Mandelli F, Amadori S, Rajnoldi AC, di Montezemolo LC, Madon E, Masera G, Meloni G, Pacilli L, Paolucci G, Pastore G, Rosito P, Uderzo C, Vecchi V (1980) Discontinuing therapy in childhood acute lymphocytic leukaemia. Cancer 46: 1319–1323

    Article  PubMed  CAS  Google Scholar 

  33. Medical Research Council (1971) Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (B.C.G), intermittent methotrexate, and no therapy after a two-month intensive cytotoxic regimen. Br Med J 4: 189–194

    Article  Google Scholar 

  34. Medical Research Council (1978) Testicular disease in acute lymphoblastic leukaemia in childhood. Br Med J 1: 334–338

    Article  Google Scholar 

  35. Medical Research Council (1982) Duration of chemotherapy in childhood acute lymphoblastic leukemia (ALL). Med Pediatr Oncol (in press)

    Google Scholar 

  36. Miller DR (1975) Prognostic factors in childhood leukemia. J Pediatr 87: 672–676

    Article  PubMed  CAS  Google Scholar 

  37. Miller DR, Leikin S, Albo V, Vitale L, Sather H, Coccia P, Nesbit M, Karon M, Hammond D (1980) Use of prognostic factors in improving the design and efficiency of clinical trials in childhood leukemia: Children’s Cancer Study Group report. Cancer treat Rep 64: 381–392

    PubMed  CAS  Google Scholar 

  38. Miller DR, Leikin S, Albo V, Sather H, Hammond D (1981) Prognostic importance of morphology (FAB classification) in childhood acute lymphoblastic leukaemia ( ALL ). Br J Haematol 48: 199–206

    PubMed  CAS  Google Scholar 

  39. Nesbit ME, Robison LL, Ortega JA, Sather HN, Donaldson M, Hammond D (1980) Testicular relapse in childhood acute lymphoblastic leukemia: association with pretreatment, patient characteristics and treatment. Cancer 45: 2009–2016

    Article  PubMed  Google Scholar 

  40. Nesbit ME, D’Angio GJ, Sather HN, Robison LL, Ortega J, Donaldson M, Hammond GD (1981a) Effect of isolated central nervous system leukaemia on bone marrow remission and survival in childhood acute lymphoblastic leukaemia: association with pretreatment, patient characteristics and treatment. Lancet 1: 1386–1389

    Article  Google Scholar 

  41. Nesbit ME, Sather HN, Robison LL, Ortega J, Littman PS, D’Angio GJ, Hammond GD (1981b) Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: comparison of 1,800 rad and 2,400 rad. Lancet 1: 461–466

    Article  PubMed  Google Scholar 

  42. Netzel B, Haas RJ, Rodt H, Kolb HJ, Thierfelder S (1980) Immunological conditioning of bone marrow for autotransplantation in childhood acute lymphoblastic leukaemia. Lancet 1: 1330–1332

    Article  PubMed  CAS  Google Scholar 

  43. Ninane J, Chessells JM (1981) Serious infections during continuing treatment of acute lymphoblastic leukaemia. Arch Dis Child 56: 841–844

    Article  PubMed  CAS  Google Scholar 

  44. Ortega JA, Nesbit ME, Donaldson MII, Hittle RE, Weiner J, Karon M, Hammond D (1977) L-asparaginase, vincristine and prednisone for induction of first remission in acute lymphocytic leukaemia. Cancer Res 37: 535–540

    PubMed  CAS  Google Scholar 

  45. Palmer MK, Hann I, Jones PM, Evans DIK (1980) A score at diagnosis for predicting length of remission in childhood lymphoblastic leukaemia. Br J Cancer 42: 841–849

    Article  PubMed  CAS  Google Scholar 

  46. Prentice HG, Smyth JF, Ganeshaguru K, Wonke B, Bradstock KF, Janossy G, Goldstone AH, Hoffbrand AV (1980) Remission induction with adenosine-deaminase inhibitor 2’-deoxycoformycin in thylymphoblastic leukaemia. Lancet 2: 170–172

    Article  PubMed  CAS  Google Scholar 

  47. Prentice HG, Russell NH, Lee N, Ganeshaguru K, Blacklock H, Piga A, Smyth JF, Hoffbrand AV (1981) Therapeutic selectivity of and prediction of response to 2’-deoxycoformycin in acute leukaemia. Lancet 2: 1250–1253

    Article  PubMed  CAS  Google Scholar 

  48. Rapson NT, Cornbleet MA, Chessells JM, Bennett T, Hardisty RM (1980) Immunosuppression and serious infections in children with acute lymphoblastic leukaemia: a comparison of three chemotherapy regimes. Br J Haematol 45: 41–52

    Article  PubMed  CAS  Google Scholar 

  49. Ritz J, Schlossman SF (1982) Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma. Blood 59: 1–11

    PubMed  CAS  Google Scholar 

  50. Rivera G, Evans WE, Dahl GV, Yee GC, Pratt CB (1980) Phase 1 clinical and pharmacokinetic study of 4’(9-acridimylamino-methanesulfon-m-aniside) in children with cancer. Cancer Res 40: 4250–4253

    PubMed  CAS  Google Scholar 

  51. Rubinstein LJ, Herman MM, Long TF, Wilbur JR (1975) Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma. Cancer 35: 291–305

    Article  PubMed  CAS  Google Scholar 

  52. Sather H, Coccia P, Nesbit M, Level C, Hammond D (1981) Disappearance of the predictive value of prognostic variables in childhood acute lymphoblastic leukemia. Cancer 48: 370–376

    Article  PubMed  CAS  Google Scholar 

  53. Secker-Walker LM, Lawler SD, Hardisty RM (1978) Prognostic implications of chromosome findings in acute lymphoblastic leukaemia at diagnosis. Br Med J 2: 1529–1530

    Article  PubMed  CAS  Google Scholar 

  54. Seeker-Walker LM, Swansbury GJ, Hardisty R, Sallan SE, Garson OM, Sakurai M, Lawler SD (1982) Cytogenetics of acute lympoblastic leukaemia in children as a factor in the prediction of long term survival. Br J Haematol (in press)

    Google Scholar 

  55. Selby PJ, Powles RL, Jameson BJ, Kay HEM, Watson JG, Thornton R, Morgenstern G, Clink HM, McElwain TJ, Prentice HG, Corringham R, Ross MG, Hoffbrand AV, Brigden D (1979) Parenteral acyclovir therapy for herpes virus infections in man. Lancet 2: 1267–1270

    Article  PubMed  CAS  Google Scholar 

  56. Simone JV (1976) Factors that influence remission duration in acute lymphocytic leukaemia. Br J Haematol 32: 465–472

    Article  PubMed  CAS  Google Scholar 

  57. Sullivan MP, Perez CA, Herson J, Silva-Sousa M, Land V, Dyment PG, Cahn R, Ayala AG (1980) Radiotherapy (2,500 rad) for testicular leukemia. Local control and subsequent clinical events: A South-West Oncology Group study. Cancer 46: 508–515

    Article  PubMed  CAS  Google Scholar 

  58. Thiel E, Rodt H, Huhn D, Netzel B, Grosse-Wilde H, Ganeshaguru K, Thierfelder S (1980) Multimarker classification of acute lymphoblastic leukemia: evidence for further T sub-groups and evaluation of their clinical significance. Blood 56: 759–772

    PubMed  CAS  Google Scholar 

  59. Vogler LB, Crist WM, Bockman DE, Pearl ER, Lawton AR, Cooper MD (1978) Pre-B-cell leukemia. A new phenotype of childhood lymphoblastic leukemia. New Engl J Med 298: 872–878

    Article  PubMed  CAS  Google Scholar 

  60. Wells RJ, Weetman RM, Baehner RL (1980) The impact of isolated central nervous system relapse following initial complete remission in childhood acute lymphocytic leukemia. J Pediatr 97: 429–432

    Article  PubMed  CAS  Google Scholar 

  61. Willoughby MLN (1976) Treatment of overt meningeal leukaemia in children: results of second MRC meningeal leukaemia trial. Br Med J 1: 864–867

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Hardisty, R.M. (1983). Acute Lymphoblastic Leukaemia: Achievements and Prospects. In: Duncan, W. (eds) Paediatric Oncology. Recent Results in Cancer Research, vol 88. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82034-2_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-82034-2_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-82036-6

  • Online ISBN: 978-3-642-82034-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics